Berg, LLC (Berg)

Oncology Corporate Profile

HQ Location

500 Old Connecticut Path, Building 8
Framingham, MA 1701

Company Description

Berg Pharma focuses research on understanding how alterations in metabolism relate to disease onset. The company has a deep pipeline of early-stage technologies in CNS diseases and metabolic diseases that complement its late-stage clinical trial activity in cancer and prevention of chemotoxicity. Armed with use of the Berg Interrogative Biology™ discovery platform that translates biological output into therapeutic candidates, Berg Pharma is well positioned for rapid commercialization of its intellectual capital.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
BP-31510unknownVarious cancer typesI

View additional information on product candidates here »


Recent News Headlines

There are no news items to display